Covid-19: why mix and match vaccines?

Loading player...
The Com-Cov trial run by the Oxford Vaccine Group in the UK will be testing the efficacy and safety of a ‘mix and match’ approach to immunisation. By giving some participants either the Pfizer/BioNTech or Oxford/AstraZeneca vaccine, and a second dose of the other, the trial aims to find out if combining different jabs offers sufficient protection. Sarah Boseley speaks to Dr Peter English about where this technique has been used in the past, why it could be beneficial, and how mixing vaccines actually works. Help support our independent journalism at theguardian.com/sciencepod
16 Feb 2021 English United Kingdom Science · Nature

Other recent episodes

Perimenopause is everywhere. How do you know if you’re in it?

Perimenopause has become a hot topic, with celebrities sharing their experiences and doctors offering tips and advice online. But despite the benefits of growing awareness, a rising number of women are now encountering misinformation about treatments such as HRT. Madeleine Finlay hears from Dr Paula Briggs, a consultant in sexual…
27 Oct 15 min

Elizabeth Holmes is back in the spotlight: why can’t we look away?

You Can See Everything, a documentary about the disgraced biotech company founder Elizabeth Holmes, has enjoyed a record-breaking opening in the US. It is a testament to how fascinated we remain by the convicted fraudster, but what is behind the enduring appeal? US technology editor Blake Montgomery tells Madeleine Finlay…
22 Oct 17 min

‘These risks are real’: the threat of AI bioweapons

In his annual speech on threats to the nation, Sir Ken McCallum, the head of the UK’s intelligence service, MI5, warned that AI had the potential to ‘change the stakes’ on existing and even new bioweapons. To find out why, and how, Ian Sample speaks to Dr Tom Inglesby, director…
20 Oct 15 min

Is your boss watching you? The rise of AI surveillance at work

Workers have always been monitored by their bosses, first through output targets, and then via computer software labelled ‘bossware’. But AI is transforming the capabilities of these systems, processing huge volumes of data to provide minute-by-minute accounts of activity, and productivity. To find out more, Ian Sample hears from UK…
15 Oct 17 min